Shopping Cart

Your shopping cart is currently empty

Anti-inflammatory agent 51

Name: Anti-inflammatory agent 51
Brand: TargetMol
SKU: T77582
Price: 36 USD
Availability: InStock
Rating: 5 (10 reviews)

😃Good

Catalog No. T77582Cas No. 2911610-03-0

Anti-inflammatory agent 51 is an amide/sulfonamide derivative with anti-inflammatory and potentially anti-tumor activity and inhibition of NF-κB activation, which can be used to study acute lung injury and ulcerative colitis.

Anti-inflammatory agent 51

😃Good

Purity: 99.76%

Catalog No. T77582Cas No. 2911610-03-0

Pack Size	Price	USA Warehouse	Global Warehouse
10 mg	$36	-	In Stock
25 mg	$60	-	In Stock
50 mg	$90	-	In Stock

Add to Cart

Add to Quotation

In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Questions

Batch Information

Select Batch

Purity:99.76%

Appearance:Solid

Color:Yellow

Resource Download

COA LCMS HNMR

Product Introduction

Bioactivity

Description	Anti-inflammatory agent 51 is an amide/sulfonamide derivative with anti-inflammatory and potentially anti-tumor activity and inhibition of NF-κB activation, which can be used to study acute lung injury and ulcerative colitis.
Targets&IC50	TNF-α:4.34 μM (J774A.1 cells), IL-6:0.61 μM (J774A.1 cells)
In vitro	Anti-inflammatory agent 51 (compound 11d) effectively reduces the release of IL-6 (IC50 value of 0.61 μM) and TNF-α (IC50 of 4.34 μM), decreases cytokine mRNA levels in J774A.1 cells, restores IκBα, and inhibits the nuclear translocation of phosphorylated p65 [1].
In vivo	Anti-inflammatory agent 51 (compound 11d) mitigates lipopolysaccharide (LPS)-induced acute lung injury (ALI) and ameliorates dextran sulfate sodium (DSS)-induced ulcerative colitis in mice [1].

Chemical Properties

Molecular Weight	498.51
Formula	C₂₂H₂₂N₆O₆S
Cas No.	2911610-03-0
Smiles	O=[N+]([O-])C1=CC=C(N2CCN(CC2)C3=CC=C(S(=O)(NCC4=NC=CC=C4)=O)C=C3[N+]([O-])=O)C=C1
Relative Density.	no data available

Storage & Solubility Information

Storage

store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Solubility Information

DMSO: 60 mg/mL (120.36 mM), Sonication is recommended.

Solution Preparation Table

DMSO

	1mg	5mg	10mg	50mg
1 mM	2.0060 mL	10.0299 mL	20.0598 mL	100.2989 mL
5 mM	0.4012 mL	2.0060 mL	4.0120 mL	20.0598 mL
10 mM	0.2006 mL	1.0030 mL	2.0060 mL	10.0299 mL
20 mM	0.1003 mL	0.5015 mL	1.0030 mL	5.0149 mL
50 mM	0.0401 mL	0.2006 mL	0.4012 mL	2.0060 mL
100 mM	0.0201 mL	0.1003 mL	0.2006 mL	1.0030 mL

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:

For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments

and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent

10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH₂O , the resulting working solution concentration would be 2 mg/mL.

Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSO TargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSO TargetMol | reagent stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH₂O TargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.

All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc